{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:51:03Z","timestamp":1787845863136,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Although numerous cohort studies have reported an association between antihypertensives use and depression, the exact effect of antihypertensives on depression remains unclear.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To clarify the association between antihypertensives use and risk of depression.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We retrieved relevant literature using PubMed database until August 30, 2021. Four main classes of antihypertensives, thus, angiotensin antagonists, beta blockers, calcium channel blockers and diuretics were studied. The incidence of depression was pooled based on a single drug category. Network meta-analyses were conducted to comprehensively assess the effects of the four classes of antihypertensives on the risk of depression.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of nine out of 9,557 studies involving 414,873 subjects were retrieved. The pooled results showed a positive association between the use of calcium channel blockers and symptoms of depression [odds ratio (OR): 1.09, 95% confidence interval (CI):1.06\u20131.13], while use of the angiotensin antagonists, beta blockers and diuretics was not associated with risk of depression. Subgroup analysis suggested a significant relationship between beta blockers usage and risk of depression in cohort studies (OR:1.21, 95% CI: 1.16\u20131.26). The results of network meta-analysis indicated that all other three classes of drugs increased the risk of depression: angiotensin antagonists (OR: 1.30, 95% CI: 1.04\u20131.63), beta blockers (OR: 1.53, 95% CI: 1.22\u20131.91), and calcium channel blockers (OR: 1.40, 95% CI: 1.12\u20131.75), compared with diuretics.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In conclusion, our results indicate that the use of angiotensin antagonists, beta blockers and calcium channel blockers are potential risk factors of depression.<\/jats:p>","DOI":"10.3389\/fphar.2021.777987","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T07:46:21Z","timestamp":1636357581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael N.","family":"Alolga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingxi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41371-020-0303-y","article-title":"The Association of Antihypertensive Use and Depressive Symptoms in a Large Older Population with Hypertension Living in Australia and the United States: a Cross-Sectional Study","volume":"34","author":"Agustini","year":"2020","journal-title":"J. Hum. Hypertens."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7868-7_1","article-title":"Introduction to Epidemiological Studies","volume":"1793","author":"Belbasis","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The Bidirectional Relationship of Depression and Inflammation: Double Trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","article-title":"Monotherapy with Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders","volume":"68","author":"Boal","year":"2016","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jad.2019.08.075","article-title":"Distinct Effects of Antihypertensives on Depression in the Real-World Setting: A Retrospective Cohort Study","volume":"259","author":"Cao","year":"2019","journal-title":"J. Affect Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.biopsych.2019.04.011","article-title":"Neurobiology of Resilience: Interface between Mind and Body","volume":"86","author":"Cathomas","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/5584_2016_36","article-title":"The Role of Beta-Blockers in the Treatment of Hypertension","volume":"956","author":"Cruickshank","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident Diabetes in Clinical Trials of Antihypertensive Drugs: a Network Meta-Analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2165\/00002512-200825090-00005","article-title":"Association between Depressive Symptoms and Use of HMG-CoA Reductase Inhibitors (Statins), Corticosteroids and Histamine H(2) Receptor Antagonists in Community-Dwelling Older Persons: Cross-Sectional Analysis of a Population-Based Cohort","volume":"25","author":"Feng","year":"2008","journal-title":"Drugs Aging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut-brain axis: How the Microbiome Influences Anxiety and Depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/0895-4356(96)00017-0","article-title":"The Incidence of Depression in New Users of Beta-Blockers and Selected Antihypertensives","volume":"49","author":"Gerstman","year":"1996","journal-title":"J. Clin. Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring Inconsistency in Meta-Analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"20142014","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1017\/S2045796020000542","article-title":"Bidirectional Association between Blood Pressure and Depressive Symptoms in Young and Middle-Age Adults: A Cohort Study","volume":"29","author":"Jeon","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10654-011-9641-y","article-title":"Anxiety and Depression Symptoms in Arterial Hypertension: the Influence of Antihypertensive Treatment. The HUNT Study, Norway","volume":"27","author":"Johansen","year":"2012","journal-title":"Eur. J. Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.120.15605","article-title":"Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study","volume":"76","author":"Kessing","year":"2020","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1317","DOI":"10.1097\/MD.0000000000001317","article-title":"Prevalence of Depression in Patients with Hypertension: A Systematic Review and Meta-Analysis","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/HJH.0b013e32835f5768","article-title":"Association of Hypertension with Depression in the Community: Results from the Gutenberg Health Study","volume":"31","author":"Michal","year":"2013","journal-title":"J. Hypertens."},{"key":"B20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10571-011-9656-7","article-title":"Lower Frequency of Antidepressant Use in Patients on Renin-Angiotensin-Aldosterone System Modifying Medications","volume":"31","author":"Nasr","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major Depressive Disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B22","doi-asserted-by":"publisher","first-page":"372n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: an Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B23","first-page":"770","article-title":"Depression and Heart Diseases: Leading Health Problems","volume":"29","author":"Rai\u010d","year":"2017","journal-title":"Psychiatr. Danub"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/HYPERTENSIONAHA.120.16590","article-title":"Do \u03b2-Blockers Cause Depression? Systematic Review and Meta-Analysis of Psychiatric Adverse Events during \u03b2-Blocker Therapy","volume":"77","author":"Riemer","year":"2021","journal-title":"Hypertension"},{"key":"B25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1517\/14728222.2014.902938","article-title":"Beta-blockers and Depression in Elderly Hypertension Patients in Primary Care","volume":"46","author":"Ringoir","year":"2014","journal-title":"Fam. Med."},{"key":"B26","volume-title":"Celiac Disease. Evidence Reports\/Technology Assessments","author":"Rostom","year":"2004"},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking Treatments in Frequentist Network Meta-Analysis Works without Resampling Methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jamda.2010.02.009","article-title":"Hypertension Treatment and Outcomes in US Nursing Homes: Results from the US National Nursing Home Survey","volume":"12","author":"Simonson","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.socscimed.2010.03.035","article-title":"Gender Differences in Depression in 23 European Countries. Cross-National Variation in the Gender gap in Depression","volume":"71","author":"Van de Velde","year":"2010","journal-title":"Soc. Sci. Med."},{"key":"B30","unstructured":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses\n            WellsG. A.\n            SheaB.\n            O\u2019ConnellD.\n            PetersonJ.\n            WelchV.\n            LososM.\n          2014"},{"key":"B31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ejcb.2010.05.002","article-title":"Dexamethasone Enhances the Norepinephrine-Induced ERK\/MAPK Intracellular Pathway Possibly via Dysregulation of the Alpha2-Adrenergic Receptor: Implications for Antidepressant Drug Mechanism of Action","volume":"89","author":"Yaniv","year":"2010","journal-title":"Eur. J. Cel Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jocn.2017.09.022","article-title":"Depression and Cardiovascular Disease in Elderly: Current Understanding","volume":"47","author":"Zhang","year":"2018","journal-title":"J. Clin. Neurosci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.777987\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T07:46:24Z","timestamp":1636357584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.777987\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":32,"alternative-id":["10.3389\/fphar.2021.777987"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.777987","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"article-number":"777987"}}